- Home
- TVRD vs ASLE Comparison
TVRD vs ASLE Comparison
Compare TVRD & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- ASLE
- Stock Information
- Founded
- TVRD 2017
- ASLE 2008
- Country
- TVRD United States
- ASLE United States
- Employees
- TVRD N/A
- ASLE N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- ASLE Industrial Specialties
- Sector
- TVRD Health Care
- ASLE Consumer Discretionary
- Exchange
- TVRD Nasdaq
- ASLE Nasdaq
- Market Cap
- TVRD 246.5M
- ASLE 277.0M
- IPO Year
- TVRD N/A
- ASLE N/A
- Fundamental
- Price
- TVRD $29.92
- ASLE $8.63
- Analyst Decision
- TVRD Strong Buy
- ASLE Hold
- Analyst Count
- TVRD 5
- ASLE 2
- Target Price
- TVRD $59.20
- ASLE $7.00
- AVG Volume (30 Days)
- TVRD 23.2K
- ASLE 602.4K
- Earning Date
- TVRD 08-14-2025
- ASLE 08-06-2025
- Dividend Yield
- TVRD N/A
- ASLE N/A
- EPS Growth
- TVRD N/A
- ASLE N/A
- EPS
- TVRD N/A
- ASLE 0.13
- Revenue
- TVRD N/A
- ASLE $350,583,000.00
- Revenue This Year
- TVRD N/A
- ASLE $9.98
- Revenue Next Year
- TVRD N/A
- ASLE $8.15
- P/E Ratio
- TVRD N/A
- ASLE $70.13
- Revenue Growth
- TVRD N/A
- ASLE N/A
- 52 Week Low
- TVRD $8.13
- ASLE $4.53
- 52 Week High
- TVRD $34.31
- ASLE $9.12
- Technical
- Relative Strength Index (RSI)
- TVRD 65.43
- ASLE 65.59
- Support Level
- TVRD $22.91
- ASLE $8.74
- Resistance Level
- TVRD $31.54
- ASLE $9.12
- Average True Range (ATR)
- TVRD 1.65
- ASLE 0.33
- MACD
- TVRD 0.61
- ASLE -0.05
- Stochastic Oscillator
- TVRD 81.28
- ASLE 32.88
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.